These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2316444)

  • 1. Will you make money?
    Menighan TE
    Am Pharm; 1990 Mar; NS30(3):18-9. PubMed ID: 2316444
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost containment in HMO pharmacies.
    Zuvekas A; Fox PD; Heinen L; Pollard MR
    GHAA J; 1986; 7(2):22-34. PubMed ID: 10301255
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacy directors, employers paint picture of HMO pharmacy benefit.
    Am J Health Syst Pharm; 1996 Sep; 53(18):2136, 2142. PubMed ID: 8879318
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacy benefit companies hone strategies to contain costs and improve quality.
    Edlin M
    Healthplan; 2001; 42(3):66-8, 70, 72. PubMed ID: 16296290
    [No Abstract]   [Full Text] [Related]  

  • 5. Accounting principles, revenue recognition, and the profitability of pharmacy benefit managers.
    McLean RA; Garis RI
    Res Social Adm Pharm; 2005 Mar; 1(1):118-25. PubMed ID: 17138469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicaid prescription drug coverage: state efforts to control costs.
    Gencarelli DM
    NHPF Issue Brief; 2003 May; (790):1-17. PubMed ID: 12751504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist dispensing: service or sale?
    Abood RR
    Am Pharm; 1980 Oct; NS20(10):25-9. PubMed ID: 7435364
    [No Abstract]   [Full Text] [Related]  

  • 8. The President's price guidelines made easy.
    Siecker BR
    Am Pharm; 1980 Apr; NS20(4):49-50. PubMed ID: 7386380
    [No Abstract]   [Full Text] [Related]  

  • 9. Capitation reimbursement for pharmacy services: a dissenting view.
    Gosselin RA
    Med Mark Media; 1980 Oct; 15(10):51-6. PubMed ID: 10249122
    [No Abstract]   [Full Text] [Related]  

  • 10. Adapting to the new world of pharmacy economics.
    Anderson LJ
    Am Pharm; 1984 Jul; NS24(7):33-6. PubMed ID: 6464986
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmacists primer on price discrimination.
    Roberts C
    Am Pharm; 1980 Oct; NS20(10):32-7. PubMed ID: 7435365
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacy services: achieving equitable reimbursement.
    Gagnon JP
    Med Mark Media; 1980 Oct; 15(10):38, 40, 42 passim. PubMed ID: 10249121
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug benefits in health insurance.
    Muller C
    Int J Health Serv; 1974; 4(1):157-70. PubMed ID: 4829894
    [No Abstract]   [Full Text] [Related]  

  • 14. Unlock savings through innovative pharmacy benefit design.
    Edlin M
    AHIP Cover; 2005; 46(4):14-20. PubMed ID: 16149655
    [No Abstract]   [Full Text] [Related]  

  • 15. A fee for the service of pharmacy: the time has come.
    Tanner DJ
    Hosp Pharm; 1978 Dec; 13(12):692-3, 696. PubMed ID: 10239821
    [No Abstract]   [Full Text] [Related]  

  • 16. Medicare's new drug plan: the right choice for you?
    Consum Rep; 2005 Dec; 70(12):8. PubMed ID: 16299949
    [No Abstract]   [Full Text] [Related]  

  • 17. Specialty agents with expedited approval may fuel 2015 pharmacy costs.
    Reinke T
    Manag Care; 2014 Dec; 23(12):15-6. PubMed ID: 25941736
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacy and Therapeutics Committee implications of the Medicare drug benefit.
    Penna P
    Manag Care Interface; 2004 Mar; 17(3):42-3. PubMed ID: 15098550
    [No Abstract]   [Full Text] [Related]  

  • 19. Capitation payment for pharmacy services: are we ready?
    Berger BA
    Med Mark Media; 1980 Oct; 15(10):33-6. PubMed ID: 10249120
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacy economics: freedom and ability to manage.
    Apple WS
    Am Pharm; 1981 Mar; NS21(3):29-35. PubMed ID: 7223619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.